Fund II & IIA Updates
As many of you know, we launched Fund II and IIA in 2023. With your strong support, we are thrilled to announce we closed on Fund IIA, anchored by the University of Minnesota through SSBCI funding. In 2024 we held a 2nd Fund II closing, with final close planned for 2025. We have an amazing community, and we are truly grateful for your support.
.
New Portfolio Companies
The best part of our job is investing in awesome founders, and we are delighted to have add 3 new portfolio companies during 2024: Claros Technologies, Zerigo Health, and most recently Gabbi. We also completed two follow-on investments in b.well and MDisrupt.
Fund Administration Technologies
As the expression goes... our pipeline cup runneth over! This means leveraging technology is more crucial than ever, and AI tools have become integral to our tech stack. Given the nascency of these tools, we're always interested to hear what your teams are using, so please do reach out if you've found effective fund admin tools, and we are happy to share the pros/cons of ours.
Accelerators for Fund Managers
We are all familiar with startup accelerators, and in recent years there has been a growing number of accelerators for 'emerging' fund managers (managers on Fund I to III). These accelerators are highly selective, and in 2024 we took advantage of this trend, seeking programs that provide access to a curated funding ecosystem:
Other Recognition
In 2024, Capita3 received recognition from these organizations:
Speaking and Leadership Roles
Capita3 was invited to lead or speak at a number of events, and highlights include the MATTER 51 Labs Maternal Health accelerator which Pam York co-led, and the MedTech MVP Conference panel where Kathy Tune presented on "Forecasting the Future: Leveraging Lessons from the Most Experienced Minds in Medical Device to Create a Viable Future"
.jpg?upscale=true&width=518&upscale=true&name=Capita3%20logo%20Capita3(18of127).jpg)
